Risperidone ODT 3mg Tablets

Manufacturer CADISTA Active Ingredient Risperidone Orally Disintegrating Tablets(ris PER i done) Pronunciation ris-PER-i-done
WARNING: There is a higher chance of death in older adults who take this drug for mental problems caused by dementia. Most of the deaths were linked to heart disease or infection. This drug is not approved to treat mental problems caused by dementia. @ COMMON USES: It is used to treat schizophrenia.It is used to treat bipolar disorder.It is used to treat irritation that happens with autistic disorder.It may be given to you for other reasons. Talk with the doctor.
🏷️
Drug Class
Antipsychotic
🧬
Pharmacologic Class
Atypical antipsychotic; Serotonin-Dopamine Antagonist (SDA)
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Dec 1993
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Risperidone is a medication used to treat certain mental health conditions like schizophrenia, bipolar disorder, and irritability related to autism. It works by helping to balance certain natural chemicals in the brain. The ODT (Orally Disintegrating Tablet) form dissolves quickly in your mouth, making it easier to take, especially if you have trouble swallowing pills.
πŸ“‹

How to Use This Medicine

Taking Your Medication

To take this medication correctly, follow your doctor's instructions and read all the information provided. You can take it with or without food. Continue taking the medication as directed by your doctor or healthcare provider, even if you're feeling well.

When taking the medication, make sure to:

Remove it from the blister pack only when you're ready to take it
Take it immediately after opening the blister pack
Do not store the removed medication for future use
Use dry hands to remove the tablet from the foil
Place the tablet on your tongue and let it dissolve; water is not needed
Do not swallow the tablet whole, chew, break, or crush it

Storing and Disposing of Your Medication

To store your medication properly:

Keep it at room temperature, protected from light
Store it in a dry place, away from the bathroom
Keep all medications in a safe place, out of the reach of children and pets

When disposing of your medication:

Throw away any unused or expired medication
Do not flush it down the toilet or pour it down the drain unless instructed to do so
Check with your pharmacist for guidance on the best way to dispose of medication; you may also have access to drug take-back programs in your area

Missing a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and return to your regular schedule. Do not take two doses at the same time or take extra doses.
πŸ’‘

Lifestyle & Tips

  • Avoid alcohol and other CNS depressants, as they can increase drowsiness and dizziness.
  • Be cautious when driving or operating machinery until you know how the medication affects you.
  • Stay hydrated to help prevent orthostatic hypotension.
  • Monitor your diet and engage in regular physical activity to help manage potential weight gain and metabolic changes.
  • Do not stop taking this medication suddenly without consulting your doctor, as it can lead to withdrawal symptoms or worsening of your condition.
  • Inform your doctor about all other medications, supplements, and herbal products you are taking.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: Varies by indication. For schizophrenia, initial 2 mg/day, target 4-8 mg/day. For bipolar mania, initial 2-3 mg/day, target 1-6 mg/day. For irritability associated with autistic disorder, initial 0.5 mg/day, target 0.5-3 mg/day.
Dose Range: 0.5 - 16 mg

Condition-Specific Dosing:

schizophrenia: Initial 2 mg/day, may increase by 1-2 mg/day at intervals of β‰₯24 hours to a target range of 4-8 mg/day. Max 16 mg/day.
bipolar_mania: Initial 2-3 mg/day, may adjust by 1 mg/day at intervals of β‰₯24 hours. Target range 1-6 mg/day. Max 6 mg/day.
autism_irritability: Initial 0.5 mg/day. May increase by 0.5 mg/day at intervals of β‰₯7 days. Target range 0.5-3 mg/day.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Approved for irritability associated with autistic disorder (5-16 years) and schizophrenia (13-17 years), bipolar mania (10-17 years). Dosing is weight-based for autism and age-based for schizophrenia/bipolar.
Adolescent: For schizophrenia (13-17 years): Initial 0.5 mg/day, may increase by 0.5-1 mg/day at intervals of β‰₯24 hours to a target range of 3-6 mg/day. Max 6 mg/day. For bipolar mania (10-17 years): Initial 0.5 mg/day, may increase by 0.5-1 mg/day at intervals of β‰₯24 hours to a target range of 1-2.5 mg/day. Max 6 mg/day. For irritability associated with autistic disorder (5-16 years): Initial 0.25 mg/day (for <20 kg) or 0.5 mg/day (for β‰₯20 kg), titrate slowly.
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment for mild impairment, but monitor closely.
Moderate: Initial dose should be halved (e.g., 0.5 mg twice daily or 1 mg once daily), and titration should be slower.
Severe: Initial dose should be halved (e.g., 0.5 mg twice daily or 1 mg once daily), and titration should be slower.
Dialysis: Risperidone is not significantly removed by hemodialysis. Dose adjustment as per severe renal impairment.

Hepatic Impairment:

Mild: No specific adjustment for mild impairment, but monitor closely.
Moderate: Initial dose should be halved (e.g., 0.5 mg twice daily or 1 mg once daily), and titration should be slower.
Severe: Initial dose should be halved (e.g., 0.5 mg twice daily or 1 mg once daily), and titration should be slower.

Pharmacology

πŸ”¬

Mechanism of Action

Risperidone is a selective monoaminergic antagonist with high affinity for serotonin 5-HT2A and dopamine D2 receptors. It also antagonizes alpha1-adrenergic and, to a lesser extent, H1-histaminergic and alpha2-adrenergic receptors. Antagonism at other receptors is less potent. The combined D2 and 5-HT2A antagonism is thought to contribute to its antipsychotic effects, with 5-HT2A antagonism potentially mitigating D2-mediated extrapyramidal symptoms (EPS).
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Approximately 70% (oral solution/tablet). ODT is bioequivalent to conventional tablets.
Tmax: Risperidone: Approximately 1 hour. 9-hydroxyrisperidone (active metabolite): Approximately 3 hours (extensive metabolizers) to 17 hours (poor metabolizers).
FoodEffect: Food does not affect the rate or extent of absorption.

Distribution:

Vd: 1-2 L/kg
ProteinBinding: Risperidone: Approximately 90% (to albumin and alpha1-acid glycoprotein). 9-hydroxyrisperidone: Approximately 77%.
CnssPenetration: Yes

Elimination:

HalfLife: Risperidone: Approximately 3 hours. 9-hydroxyrisperidone: Approximately 20-24 hours (extensive metabolizers) to 30 hours (poor metabolizers).
Clearance: Not available (variable due to metabolism)
ExcretionRoute: Renal (approximately 70%), Fecal (approximately 14%)
Unchanged: Approximately 35-45% of the dose is excreted in urine as risperidone and 9-hydroxyrisperidone.
⏱️

Pharmacodynamics

OnsetOfAction: Acute agitation: Hours to days. Full antipsychotic effect: Several weeks.
PeakEffect: Acute agitation: Days to weeks. Full antipsychotic effect: Weeks.
DurationOfAction: Due to the long half-life of the active metabolite (9-hydroxyrisperidone), effects persist for approximately 24 hours with once-daily dosing.

Safety & Warnings

⚠️

BLACK BOX WARNING

Increased Mortality in Elderly Patients with Dementia-Related Psychosis: Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Risperidone is not approved for the treatment of dementia-related psychosis.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion
+ Feeling sleepy
+ Unusual thirst or hunger
+ Passing urine more often
+ Flushing
+ Fast breathing
+ Breath that smells like fruit
Severe dizziness or passing out
Changes in behavior or mood
Shakiness, trouble moving around, or stiffness
Urination problems, such as inability to pass urine or changes in urine output
Trouble swallowing or speaking
Difficulty focusing
Seizures
Changes in eyesight
Shortness of breath
Drooling
Feeling extremely hot or cold
Hormonal changes, including:
+ Enlarged breasts
+ Nipple discharge
+ Erectile dysfunction or changes in menstrual cycle
Sexual problems, such as:
+ Decreased interest in sex
+ Ejaculation problems
Prolonged or painful erections (lasting more than 4 hours), which can lead to permanent sexual dysfunction if left untreated
Neuroleptic malignant syndrome (NMS), a rare but potentially life-threatening condition, characterized by:
+ Fever
+ Muscle cramps or stiffness
+ Dizziness
+ Severe headache
+ Confusion
+ Changes in thinking or behavior
+ Fast or irregular heartbeat
+ Excessive sweating
Low white blood cell count, which can increase the risk of infection; if you have a history of low white blood cell count, inform your doctor and seek medical attention if you experience:
+ Fever
+ Chills
+ Sore throat
Tardive dyskinesia, a rare but potentially irreversible condition, characterized by:
+ Involuntary body movements
+ Problems with tongue, face, mouth, or jaw movements, such as tongue sticking out, puffing cheeks, mouth puckering, or chewing

Other Possible Side Effects

While many people may not experience any side effects or only minor ones, it's essential to be aware of the following potential side effects:

Weight gain
Restlessness
Dizziness, sleepiness, tiredness, or weakness
Anxiety
Gastrointestinal problems, such as:
+ Constipation
+ Diarrhea
+ Stomach pain
+ Upset stomach
+ Nausea or vomiting
Heartburn
Dry mouth
Changes in appetite
Common cold symptoms
Headache
Sleep disturbances
* Back, muscle, arm, or leg pain

If you experience any of these side effects or have concerns, contact your doctor or seek medical attention. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Fever, muscle stiffness, confusion, sweating, or fast/irregular heartbeat (signs of Neuroleptic Malignant Syndrome)
  • Uncontrolled muscle movements, especially of the face, tongue, or limbs (signs of tardive dyskinesia)
  • Dizziness or fainting, especially when standing up (orthostatic hypotension)
  • Difficulty swallowing
  • New or worsening high blood sugar symptoms (increased thirst, increased urination, increased hunger)
  • Breast enlargement, milk production, or missed periods (hyperprolactinemia)
  • Prolonged or painful erection (priapism)
  • Signs of infection (fever, sore throat)
  • Seizures
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This is crucial to avoid potential interactions between this medication and other substances.
* Any existing health problems, as this medication may interact with certain conditions.

To ensure your safety, it is vital to verify that this medication is compatible with all your medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Until you know how this medication affects you, avoid driving and other activities that require you to be alert. To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying down position, and be cautious when climbing stairs.

Potential Side Effects and Risks
It may take several weeks to experience the full effects of this medication. Be aware that high blood sugar, diabetes, high cholesterol, and weight gain have been associated with similar medications, which may increase the risk of heart and brain blood vessel disease.

Monitoring and Follow-up
Regularly check your blood sugar levels as instructed by your doctor. Additionally, have your blood work checked as directed by your doctor and discuss the results with them.

Interactions with Other Substances
Avoid consuming alcohol while taking this medication. Before using marijuana, cannabis, or prescription/over-the-counter medications that may cause drowsiness, consult with your doctor.

Precautions in Hot Weather and Physical Activity
Be cautious in hot weather or during physical activity, and drink plenty of fluids to prevent dehydration.

Dizziness and Fall Risk
This medication may cause dizziness, drowsiness, and impaired balance, which can increase the risk of falls, broken bones, and other health problems.

Special Considerations

If you have phenylketonuria (PKU), consult with your doctor, as some products contain phenylalanine.
Older adults with dementia who take medications like this one have a higher risk of stroke, which can be fatal. This medication is not approved for treating dementia-related mental health issues.
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
This medication may affect fertility, but this effect is reversible when the medication is stopped. If you have concerns, discuss them with your doctor.
If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor to discuss the benefits and risks to you and your baby.
Taking this medication during the third trimester of pregnancy may cause side effects or withdrawal symptoms in the newborn.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Drowsiness
  • Sedation
  • Tachycardia (fast heart rate)
  • Hypotension (low blood pressure)
  • QT prolongation
  • Extrapyramidal symptoms (e.g., muscle stiffness, tremors)
  • Seizures

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Management is supportive, including maintaining an open airway, ensuring adequate oxygenation and ventilation, and monitoring cardiac function (ECG) and vital signs. Activated charcoal may be considered if ingested recently.

Drug Interactions

πŸ”΄

Major Interactions

  • CNS depressants (e.g., alcohol, opioids, benzodiazepines): Enhanced sedation and CNS depression.
  • CYP2D6 inhibitors (e.g., fluoxetine, paroxetine, quinidine): Increase plasma concentrations of risperidone and decrease 9-hydroxyrisperidone, leading to increased overall active moiety.
  • CYP3A4 inducers (e.g., carbamazepine, rifampin, phenytoin): Decrease plasma concentrations of risperidone and 9-hydroxyrisperidone, potentially reducing efficacy.
  • Dopamine agonists (e.g., levodopa, bromocriptine): Risperidone may antagonize their effects.
  • Drugs that prolong QT interval (e.g., Class IA and III antiarrhythmics, moxifloxacin, thioridazine): Additive QT prolongation risk.
  • Antihypertensives: Additive hypotensive effects.
🟑

Moderate Interactions

  • Cimetidine, ranitidine: May increase risperidone levels (minor effect).
  • Verapamil: May increase risperidone and 9-hydroxyrisperidone levels.
  • Furosemide: Increased mortality in elderly dementia patients when co-administered with risperidone (observational study, mechanism unclear).

Monitoring

πŸ”¬

Baseline Monitoring

Weight and Height

Rationale: Risk of weight gain, especially in children and adolescents.

Timing: Before initiation

Blood Pressure and Heart Rate

Rationale: Risk of orthostatic hypotension and tachycardia.

Timing: Before initiation (supine and standing)

Fasting Plasma Glucose

Rationale: Risk of hyperglycemia and diabetes.

Timing: Before initiation

Lipid Panel (Fasting)

Rationale: Risk of dyslipidemia.

Timing: Before initiation

Complete Blood Count (CBC)

Rationale: Rare risk of leukopenia/neutropenia/agranulocytosis.

Timing: Before initiation

Liver Function Tests (LFTs)

Rationale: To assess baseline hepatic function.

Timing: Before initiation

Renal Function Tests (Creatinine, BUN)

Rationale: To assess baseline renal function, as dose adjustments are needed in impairment.

Timing: Before initiation

Electrocardiogram (ECG)

Rationale: To assess for baseline QT prolongation, especially in patients with cardiac risk factors.

Timing: Before initiation (if clinically indicated)

Prolactin Levels

Rationale: Risk of hyperprolactinemia.

Timing: Before initiation (if clinically indicated or symptomatic)

Abnormal Involuntary Movement Scale (AIMS)

Rationale: To establish baseline for tardive dyskinesia.

Timing: Before initiation

πŸ“Š

Routine Monitoring

Weight and Height

Frequency: Monthly for first few months, then quarterly.

Target: Maintain healthy BMI.

Action Threshold: Significant weight gain (e.g., >5% of baseline) warrants intervention.

Blood Pressure and Heart Rate

Frequency: Monthly for first few months, then quarterly.

Target: Within normal limits, no significant orthostatic changes.

Action Threshold: Persistent orthostatic hypotension or significant tachycardia.

Fasting Plasma Glucose

Frequency: At 3 months, then annually.

Target: <100 mg/dL

Action Threshold: β‰₯100 mg/dL (prediabetes) or β‰₯126 mg/dL (diabetes).

Lipid Panel (Fasting)

Frequency: At 3 months, then annually.

Target: LDL <100 mg/dL, HDL >40 mg/dL, Triglycerides <150 mg/dL

Action Threshold: Significant dyslipidemia.

Abnormal Involuntary Movement Scale (AIMS)

Frequency: Annually (more frequently if symptoms develop).

Target: No abnormal movements.

Action Threshold: Emergence or worsening of involuntary movements.

Prolactin Levels

Frequency: As clinically indicated (e.g., if symptoms of hyperprolactinemia occur).

Target: Within normal limits.

Action Threshold: Elevated levels with associated symptoms (e.g., amenorrhea, galactorrhea, gynecomastia, sexual dysfunction).

πŸ‘οΈ

Symptom Monitoring

  • Extrapyramidal symptoms (EPS): Dystonia, akathisia, parkinsonism, tardive dyskinesia
  • Orthostatic hypotension (dizziness, lightheadedness upon standing)
  • Sedation/drowsiness
  • Weight gain
  • Hyperglycemia (increased thirst, urination, hunger)
  • Dyslipidemia
  • Hyperprolactinemia (galactorrhea, amenorrhea, gynecomastia, sexual dysfunction)
  • Neuroleptic Malignant Syndrome (NMS): Fever, muscle rigidity, altered mental status, autonomic instability
  • Seizures
  • QT prolongation (palpitations, syncope)
  • Dysphagia
  • Priapism
  • Body temperature dysregulation

Special Patient Groups

🀰

Pregnancy

Category C. Studies in animals have shown adverse effects on the fetus. There are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Neonates exposed to antipsychotic drugs during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery.

Trimester-Specific Risks:

First Trimester: Potential for developmental toxicity based on animal studies; human data limited.
Second Trimester: Limited human data; animal studies suggest potential for adverse effects.
Third Trimester: Risk of extrapyramidal and/or withdrawal symptoms in neonates (e.g., agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress, feeding disorder). These complications have varied in severity; while in some cases symptoms have been self-limited, in other cases neonates have required intensive care support and prolonged hospitalization.
🀱

Lactation

Risperidone and its active metabolite are excreted in human breast milk. The decision to breastfeed should consider the developmental and health benefits of breastfeeding, the mother’s clinical need for risperidone, and any potential adverse effects on the breastfed infant from risperidone or from the underlying maternal condition. Monitor breastfed infants for sedation, poor feeding, and developmental milestones.

Infant Risk: L3 (Moderately safe). Potential for sedation, irritability, poor feeding, and weight gain in the infant. Monitor infant closely.
πŸ‘Ά

Pediatric Use

Approved for specific indications: schizophrenia (13-17 years), bipolar mania (10-17 years), and irritability associated with autistic disorder (5-16 years). Children and adolescents may be more susceptible to weight gain, metabolic changes, and hyperprolactinemia. Close monitoring of growth, weight, metabolic parameters, and prolactin levels is essential.

πŸ‘΄

Geriatric Use

Elderly patients with dementia-related psychosis treated with risperidone are at an increased risk of death (Black Box Warning). Increased risk of cerebrovascular adverse events (e.g., stroke, transient ischemic attack) in elderly patients with dementia. Start with lower doses and titrate slowly due to potential for increased sensitivity to adverse effects (e.g., orthostatic hypotension, sedation, EPS).

Clinical Information

πŸ’Ž

Clinical Pearls

  • Risperidone ODT (Orally Disintegrating Tablet) is useful for patients who have difficulty swallowing pills or who may try to 'cheek' or hide their medication.
  • The ODT formulation should be placed on the tongue and allowed to dissolve, then swallowed with or without water. Do not chew or crush.
  • Monitor patients closely for metabolic side effects (weight gain, hyperglycemia, dyslipidemia), especially in children and adolescents.
  • Hyperprolactinemia is a common side effect; monitor for symptoms like galactorrhea, amenorrhea, gynecomastia, and sexual dysfunction.
  • Titrate dose slowly to minimize orthostatic hypotension and other dose-related side effects.
  • Educate patients and caregivers about the Black Box Warning regarding increased mortality in elderly patients with dementia-related psychosis.
  • Consider the long half-life of the active metabolite (9-hydroxyrisperidone) when adjusting doses or assessing steady-state effects.
πŸ”„

Alternative Therapies

  • Other atypical antipsychotics (e.g., Olanzapine, Quetiapine, Aripiprazole, Ziprasidone, Lurasidone, Cariprazine, Brexpiprazole)
  • Typical antipsychotics (e.g., Haloperidol, Chlorpromazine) - generally less preferred due to higher EPS risk
  • Mood stabilizers (e.g., Lithium, Valproate, Carbamazepine) for bipolar disorder
  • SSRIs/SNRIs for mood/anxiety symptoms (if comorbid)
  • Behavioral therapies and psychosocial interventions
πŸ’°

Cost & Coverage

Average Cost: Varies widely, typically $10-$100+ per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (generic), Tier 3 or higher (brand)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about your medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek medical attention. When seeking help, be prepared to provide details about the medication taken, the amount, and the time it happened.